S 3394 United States Senate · 117th Congress

Emergency Use Transparency Act

Summary
Emergency Use Transparency Act This bill expands existing statutory provisions requiring the Food and Drug Administration (FDA) to publish notices of authorizations, terminations, or revocations of emergency use authorizations for medical products. Specifically, the bill requires the FDA to publish such notices on its website. The bill also allows the FDA's disclosures to include a summary of data or information from additional types of submissions.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2021
Committee Review
Floor Vote
President
Introduced Dec 14, 2021 Last action Dec 14, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Dec 14, 2021
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Dec 14, 2021
Introduced
Introduced in Senate
upper
1 primary · 2 co-sponsors

Sponsors